Alkem Laboratories Ltd (ALKEM) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Alkem Laboratories Ltd reported sales of ₹3,740 Cr, operating profit of ₹766 Cr (OPM 20%) and net profit of ₹521 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
ALKEM quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 3,415 3,374 3,144 3,371 4,001 3,737 3,603 3,740 Expenses 2,662 2,615 2,752 2,632 3,080 2,909 3,086 2,974 Operating Profit 753 759 391 739 921 828 517 766 OPM 22% 23% 12% 22% 23% 22% 14% 20% Other Income 134 93 146 149 104 90 65 153 Interest 28 36 28 30 35 42 54 47 Depreciation 79 85 112 88 94 95 106 100 Profit before tax 780 731 396 771 896 781 423 772 Tax 10% 12% 18% 13% 13% 16% 40% 32% Net Profit 702 641 322 668 779 653 251 521 EPS in Rs 57.6 52.34 25.58 55.56 63.99 53.19 19.78 43.49
ALKEM profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 10,634 11,599 12,668 12,965 14,712 15,081 Expenses 8,580 9,977 10,419 10,452 11,706 12,049 Operating Profit 2,054 1,622 2,249 2,512 3,007 3,032 OPM 19% 14% 18% 19% 20% 20% Other Income 146 101 186 494 407 412 Interest 52 107 112 122 161 178 Depreciation 304 310 299 357 382 395 Profit before tax 1,844 1,305 2,023 2,527 2,871 2,872 Tax 9% 23% 10% 12% 18% - Net Profit 1,680 1,007 1,811 2,215 2,351 2,204 EPS in Rs 137.63 82.31 150.19 181.11 192.51 180.45 Dividend Payout 25% 61% 27% 25% 28% -
ALKEM balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 24 24 24 24 24 Reserves 9,021 10,288 11,961 13,322 13,796 Borrowings 1,397 1,418 1,381 2,356 2,047 Other Liabilities 3,315 3,844 4,325 4,586 4,991 Total Liabilities 13,757 15,575 17,691 20,287 20,858 Fixed Assets 2,683 2,873 2,852 3,319 3,871 CWIP 323 159 548 653 282 Investments 622 484 1,846 2,533 1,869 Other Assets 10,129 12,060 12,445 13,783 14,836 Total Assets 13,757 15,575 17,691 20,287 20,858
ALKEM cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 1,111 1,682 1,948 1,913 1,963 Cash from Investing Activity -1,433 120 -1,011 -1,288 -1,682 Cash from Financing Activity 380 -1,761 -1,145 -811 -503 Net Cash Flow 58 42 -207 -186 -222 Free Cash Flow 783 1,453 1,761 1,278 1,476 CFO/OP 73% 121% 105% 96% 86%
ALKEM ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 65 67 65 69 74 Inventory Days 262 194 197 224 239 Days Payable 102 87 129 148 161 Cash Conversion Cycle 225 174 132 145 152 Working Capital Days 31 66 135 123 123 ROCE 18% 14% 20% 20% 21%